DepoMed, Inc. (NASDAQ:DEPO)

CAPS Rating: 4 out of 5

A specialty pharmaceutical company focused on the development and commercialization of differentiated products that address growing markets and are based on proprietary oral drug delivery technologies.


Player Avatar siri22 (< 20) Submitted: 11/13/2011 4:06:17 PM : Outperform Start Price: $4.80 DEPO Score: +174.68

Hurt bt abt. But graise launch 150m in cash

Featured Broker Partners